Cases & Deals

Invion enters into strategic alliance with The Cho Group

Clients Invion Limited

Jones Day represented Invion Limited, an ASX listed life sciences company, in a strategic alliance with The Cho Group, a Hong Kong-based group that funds and has successfully commercialized a number of unique and advanced technologies, pursuant to which Invion acquired exclusive rights to proprietary photodynamic therapy technology for the treatment of cancer developed by The Cho Group. The transaction also involved a placement of Invion shares to The Cho Group and Invion conducting a non-renounceable pro rata rights issue, which was fully underwritten by The Cho Group.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.